{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:59:00Z","timestamp":1791885540216,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder with complex gut microbiome involvement. While bacterial dysbiosis in NAFLD has been widely studied, the role of the gut virome remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We profiled gut viral communities from 90 NAFLD patients and 90 non-NAFLD controls using whole-metagenome shotgun sequencing. Viral taxonomic composition, host associations, and functional gene repertoires were analyzed. Serum metabolomic data were integrated to assess virus\u2013metabolite interactions, and random forest models were constructed to evaluate the diagnostic potential of viral signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall viral diversity showed no significant differences between NAFLD and controls, but subtle compositional shifts were detected at the vOTU level, with 105 viruses enriched in NAFLD and 185 in non-NAFLD individuals. NAFLD-enriched phages primarily targeted Bacteroides, whereas non-NAFLD-enriched phages were associated with beneficial genera such as Faecalibacterium, Oscillibacter, and Prevotella. Functional annotation revealed a reorganization of viral gene repertoires: genes involved in DNA recombination and horizontal transfer (e.g. int, recD) were depleted, while those related to host interaction and stress response (e.g. xerD, dnaK, hipB) were enriched in NAFLD, indicating enhanced viral persistence and host communication. Serum metabolomic profiling identified 8 differential metabolites, and correlation analysis linked specific vOTUs with altered metabolic pathways. A random forest model based on viral features achieved an AUC of 0.758, outperforming the bacterial model, while integration of viral and bacterial features further improved prediction (AUC\u2009=\u20090.837).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The gut virome in NAFLD undergoes compositional and functional remodeling characterized by a shift toward host-adaptive, metabolically interactive viral communities. These viral alterations are closely associated with host metabolic changes and demonstrate strong diagnostic potential. Our findings highlight the virome as an overlooked yet critical component of the gut ecosystem in NAFLD pathogenesis and as a promising source of noninvasive biomarkers for disease prediction and monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-025-07443-w","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:15:54Z","timestamp":1764346554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization of the gut virome in patients with nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Lvyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanliang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"7443_CR1","doi-asserted-by":"publisher","first-page":"100191","DOI":"10.1016\/j.engmic.2025.100191","volume":"5","author":"RH Lathakumari","year":"2025","unstructured":"Lathakumari RH, et al. The gut virome and human health: from diversity to personalized medicine. Eng Microbiol. 2025;5(1):100191.","journal-title":"Eng Microbiol"},{"issue":"6","key":"7443_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/MOG.0000000000000885","volume":"38","author":"S Hiba","year":"2022","unstructured":"Hiba S, Colin H. The gut virome in health and disease: new insights and associations. Curr Opin in Gastroenterol. 2022;38(6):549\u201354.","journal-title":"Curr Opin In Gastroenterol"},{"issue":"5","key":"7443_CR3","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","volume":"159","author":"S Lang","year":"2020","unstructured":"Lang S, et al. Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology. 2020;159(5):1839\u201352.","journal-title":"Gastroenterology"},{"key":"7443_CR4","doi-asserted-by":"crossref","unstructured":"Friedman SL, et al. Mechanisms of NAFLD development and therapeutic strategies. 2018;24(7):908\u201322.","DOI":"10.1038\/s41591-018-0104-9"},{"key":"7443_CR5","doi-asserted-by":"crossref","unstructured":"Byrne CD, Targher GJJoh. NAFLD: a multisystem disease. 2015;62(1):S47\u201364.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"7443_CR6","doi-asserted-by":"crossref","unstructured":"Wei S, et al. NAFLD and NASH: etiology, targets and emerging therapies. 2024;29(3):103910.","DOI":"10.1016\/j.drudis.2024.103910"},{"key":"7443_CR7","doi-asserted-by":"crossref","unstructured":"Wong W-K, Chan W-KJCt. Nonalcoholic fatty liver disease: a global perspective. 2021;43(3):473\u201399.","DOI":"10.1016\/j.clinthera.2021.01.007"},{"key":"7443_CR8","unstructured":"Gentile CL, Pagliassotti MJJTJonb. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. 2008;19(9):567\u201376."},{"key":"7443_CR9","doi-asserted-by":"crossref","unstructured":"Chen Z, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. 2020;152:116\u201341.","DOI":"10.1016\/j.freeradbiomed.2020.02.025"},{"key":"7443_CR10","doi-asserted-by":"crossref","unstructured":"Brenner C, et al. Decoding cell death signals in liver inflammation. 2013;59(3):583\u201394.","DOI":"10.1016\/j.jhep.2013.03.033"},{"key":"7443_CR11","doi-asserted-by":"crossref","unstructured":"Li L, et al. Gut microbiome and NAFLD: impact and therapeutic potential. Front Microbiol. 2024.","DOI":"10.3389\/fmicb.2024.1500453"},{"key":"7443_CR12","doi-asserted-by":"crossref","unstructured":"Fujimoto K, et al. Characterization of the human gut virome in metabolic and autoimmune diseases. 2022;42(1):32.","DOI":"10.1186\/s41232-022-00218-6"},{"key":"7443_CR13","doi-asserted-by":"crossref","unstructured":"Lang S, et al. Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. 2020;159(5):1839\u201352.","DOI":"10.1053\/j.gastro.2020.07.005"},{"key":"7443_CR14","unstructured":"Hsu CL, et al. Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome. 2023;77(6):2073\u201383."},{"key":"7443_CR15","doi-asserted-by":"crossref","unstructured":"Leung H, et al. Risk assessment with gut microbiome and metabolite markers in NAFLD development. 2022;14(648):eabk0855.","DOI":"10.1126\/scitranslmed.abk0855"},{"issue":"17","key":"7443_CR16","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"4","key":"7443_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SLJNm. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357\u201359.","journal-title":"Nat Methods"},{"key":"7443_CR18","doi-asserted-by":"crossref","unstructured":"Blanco-M\u00edguez A, et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. 2023;41(11):1633\u201344.","DOI":"10.1038\/s41587-023-01688-w"},{"key":"7443_CR19","doi-asserted-by":"crossref","unstructured":"Li S, et al. Cataloguing and profiling of the gut virome in Chinese populations uncover extensive viral signatures across common diseases. BioRxiv. 2022;2022.12. 27.522048.","DOI":"10.1101\/2022.12.27.522048"},{"key":"7443_CR20","doi-asserted-by":"crossref","unstructured":"Gregory AC, et al. Marine DNA viral macro-and microdiversity from Pole to Pole. 2019;177(5):1109\u201323. e14.","DOI":"10.1016\/j.cell.2019.03.040"},{"issue":"17","key":"7443_CR21","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1016\/j.cell.2024.06.018","volume":"187","author":"E Piperni","year":"2024","unstructured":"Piperni E, et al. Intestinal blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries. Cell. 2024;187(17):4554\u201370.e18.","journal-title":"Cell"},{"key":"7443_CR22","doi-asserted-by":"crossref","unstructured":"Yin H, et al. Ipev: identification of prokaryotic and Eukaryotic virus-derived sequences in virome using deep learning. 2023;2023.05.28.541705.","DOI":"10.1101\/2023.05.28.541705"},{"issue":"1","key":"7443_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using diamond. Nat Methods. 2015;12(1):59\u201360.","journal-title":"Nat Methods"},{"issue":"D1","key":"7443_CR24","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, et al. Kegg: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"7443_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1654-1103.2003.tb02228.x","volume":"14","author":"P Dixon","year":"2003","unstructured":"Dixon P. Vegan, a package of R functions for community ecology. J Veg Sci. 2003;14(6):927\u201330.","journal-title":"J Veg Sci"},{"key":"7443_CR26","doi-asserted-by":"crossref","unstructured":"Schwimmer JB, et al. Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease. 2019;157(4):1109\u201322.","DOI":"10.1053\/j.gastro.2019.08.040"},{"key":"7443_CR27","doi-asserted-by":"crossref","unstructured":"Aron-Wisnewsky J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. 2020;17(5):279\u201397.","DOI":"10.1038\/s41575-020-0269-9"},{"key":"7443_CR28","doi-asserted-by":"crossref","unstructured":"Fang J, et al. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. 2022;12:997018.","DOI":"10.3389\/fcimb.2022.997018"},{"key":"7443_CR29","doi-asserted-by":"publisher","first-page":"1178744","DOI":"10.3389\/fmicb.2023.1178744","volume":"14","author":"G Liu","year":"2023","unstructured":"Liu G, et al. An independent evaluation in a CRC patient cohort of microbiome 16S rRNA sequence analysis methods: otu clustering, DADA2, and Deblur. Front Microbiol. 2023;14:1178744.","journal-title":"Front Microbiol"},{"key":"7443_CR30","doi-asserted-by":"crossref","unstructured":"Wang T, Guo X-K, Xu HJFiM. Disentangling the progression of non-alcoholic fatty liver disease in the human gut microbiota. 2021;12:728823.","DOI":"10.3389\/fmicb.2021.728823"},{"issue":"3","key":"7443_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","volume":"16","author":"S Miquel","year":"2013","unstructured":"Miquel S, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16(3):255\u201361.","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"7443_CR32","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/antiox13111358","volume":"13","author":"A Cuevas-Sierra","year":"2024","unstructured":"Cuevas-Sierra A, et al. Mediterranean diet and olive oil redox interactions on lactate dehydrogenase mediated by gut oscillibacter in patients with long-COVID-19 syndrome. Antioxidants. 2024;13(11):1358.","journal-title":"Antioxidants"},{"issue":"2","key":"7443_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0007114519000680","volume":"122","author":"G Precup","year":"2019","unstructured":"Precup G, Vodnar D-C. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. Br J Nutr. 2019;122(2):131\u201340.","journal-title":"Br J nutr"},{"key":"7443_CR34","doi-asserted-by":"crossref","unstructured":"Antraco VJ, et al. Omega-3 polyunsaturated fatty acids prevent nonalcoholic steatohepatitis (NASH) and stimulate adipogenesis. 2021;13(2):622.","DOI":"10.3390\/nu13020622"},{"key":"7443_CR35","doi-asserted-by":"crossref","unstructured":"Aziz T, et al. Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a systematic review and meta-analysis. 2024;16(8).","DOI":"10.7759\/cureus.68002"},{"key":"7443_CR36","doi-asserted-by":"crossref","unstructured":"Spooner MH, Jump DBJARoN. Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use. 2023;43(1):199\u2013223.","DOI":"10.1146\/annurev-nutr-061021-030223"},{"key":"7443_CR37","doi-asserted-by":"crossref","unstructured":"Fu Y, et al. Associations among dietary omega-3 polyunsaturated fatty acids, the gut microbiota, and intestinal immunity. 2021(1):8879227.","DOI":"10.1155\/2021\/8879227"},{"key":"7443_CR38","doi-asserted-by":"crossref","unstructured":"Farhangi MA, et al. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. 2022;92:105074.","DOI":"10.1016\/j.jff.2022.105074"},{"issue":"2","key":"7443_CR39","doi-asserted-by":"publisher","first-page":"Mdna3\u20130051","DOI":"10.1128\/microbiolspec.MDNA3-0051-2014","volume":"3","author":"A Landy","year":"2015","unstructured":"Landy A. The \u03bb Integrase site-specific recombination pathway. Microbiol Spectr. 2015;3(2):Mdna3\u20130051\u20132014.","journal-title":"Microbiol Spectr"},{"issue":"6889","key":"7443_CR40","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature00782","volume":"417","author":"KE Huber","year":"2002","unstructured":"Huber KE, Waldor MK. Filamentous phage integration requires the host recombinases XerC and XerD. Nature. 2002;417(6889):656\u201359.","journal-title":"Nature"},{"issue":"13","key":"7443_CR41","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1016\/j.jmb.2020.04.014","volume":"432","author":"R Barriot","year":"2020","unstructured":"Barriot R, et al. J-Domain proteins in bacteria and their viruses. J Mol Biol. 2020;432(13):3771\u201389.","journal-title":"J Mol Biol"},{"key":"7443_CR42","doi-asserted-by":"crossref","unstructured":"Ulius S, et al. Genomic characterization of cyanophage vB_AphaS-CL131 infecting filamentous diazotrophic cyanobacterium aphanizomenon flos-aquae reveals novel insights into virus-bacterium interactions. Am Soc For Microbiol. 2019(1).","DOI":"10.1128\/AEM.01311-18"},{"issue":"13","key":"7443_CR43","doi-asserted-by":"publisher","first-page":"10.1128\/jvi.004","DOI":"10.1128\/JVI.00402-19","volume":"93","author":"R Nazeer","year":"2019","unstructured":"Nazeer R, et al. Adenovirus E1B 55-kilodalton protein targets SMARCAL1 for degradation during infection and modulates cellular dna replication. J Virol. 2019;93(13):10.1128\/jvi.00402\u201319.","journal-title":"J Virol"},{"issue":"2","key":"7443_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-6976.2007.00099.x","volume":"32","author":"W Vollmer","year":"2008","unstructured":"Vollmer W, et al. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol Rev. 2008;32(2):259\u201386.","journal-title":"FEMS Microbiol Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07443-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:08:43Z","timestamp":1781618923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07443-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7443"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07443-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7377965\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript, and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}